Related Experiment Video
Updated: Dec 12, 2025

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
Published on: April 17, 2017
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection
Timotius Ivan Hariyanto1, Andree Kurniawan2
1Faculty of Medicine, Pelita Harapan University, Boulevard Jendral Sudirman Street, Karawaci, Tangerang, 15811, Indonesia.
Insights
Dyslipidemia, a condition affecting blood lipid levels, is linked to increased severity of coronavirus disease 2019 (COVID-19). Individuals with dyslipidemia require close monitoring to mitigate risks associated with severe COVID-19 outcomes.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- The ongoing increase in coronavirus disease 2019 (COVID-19) cases and fatalities necessitates identifying risk factors for severe outcomes.
- Dyslipidemia, a known risk factor for cardiovascular disease, is investigated for its potential role in COVID-19 severity.
Purpose of the Study:
- To analyze the association between dyslipidemia and the severity of COVID-19 infection.
Main Methods:
- A systematic literature search was conducted on the PubMed database up to July 9th, 2020.
- Articles on COVID-19 and dyslipidemia were retrieved and analyzed using Review Manager 5.4 software.
Main Results:
- Seven studies comprising 6922 patients were included in the meta-analysis.
- Dyslipidemia was found to be associated with severe COVID-19 infections, with a risk ratio of 1.39 (95% CI 1.03-1.87).
Conclusions:
- Dyslipidemia is a significant risk factor for severe outcomes in COVID-19 infections.
- Close monitoring of patients with dyslipidemia is recommended to minimize COVID-19-related risks.
Background And Aims:
The number of positive and death cases from coronavirus disease 2019 (COVID-19) is still increasing. The identification of risk factors for severe outcomes is important. Dyslipidemia has been shown as a long-known risk factor for cardiovascular disease. The aim of this study is to analyze the potential association between dyslipidemia and the severity of COVID-19 infection.
Methods:
We systematically searched the PubMed database using specific keywords related to our aims until July 9th, 2020. All articles published on COVID-19 and dyslipidemia were retrieved. Statistical analysis was done using Review Manager 5.4 software.
Results:
A total of 7 studies with a total of 6922 patients were included in our analysis. Our meta-analysis showed that dyslipidemia is associated with severe COVID-19 infections [RR 1.39 (95% CI 1.03-1.87), p = 0.03, I2 = 57%, random-effect modelling].
Conclusion:
Dyslipidemia increases the risk of the development of severe outcomes from COVID-19 infections. Patients with dyslipidemia should be monitored closely to minimize the risk of COVID-19.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Lipids: Dietary Sources and Requirements